MedTrace Logo

Hamstring Stretching in Plantar Fasciitis

NCT06139822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-11-18

No results posted yet for this study

Summary

The purpose of the study is to compare the effects of Hamstring stretching versus conventional treatment for plantar fasciitis. A randomized control trial was conducted at Cena Medical Center Rawalpindi and Midland Doctors Institute Muzaffarabaad. The sample size was 64 calculated through open-epi tool. The participants were divided into two groups, interventional and control group each having 32 participants. The study duration was 1 year. Sampling technique applied was Purposive sampling for recruitment and group randomization using flip coin method. Only 25to 45 years participants with plantar fasciitis along with hamstring tightness were included in the study. Tools used in this study are Goniometer, Visual Analogue Scale(VAS) for pain, and Functional Foot Index (FFI) for pain and disability. Data was collected before treatment at baseline and after 1st and 2nd week of the application of interventions. Data analyzed through SPSS version 25.

Conditions

  • Plantar Fasciitis of Both Feet

Interventions

OTHER

Experimental Group

Hamstring stretching is the main intervention which is being used along with convention protocol for plantar fasciitis.

OTHER

Control Group

Control group included Cold pack for 7 to 10 mins. Followed by stretching of plantar fascia .

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Lal Gul Khan, MScPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-12-31
Completion
2023-01-25

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06139822 on ClinicalTrials.gov